Clinical trial
Clinical Trial of Safety and Efficacy of Topical ABL01 Treatment of Onychomycosis
NCT03141840 is registered in ClinicalTrials.gov with Abbell AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial of Safety and Efficacy of Topical ABL01 Treatment of Onychomycosis
- Lead sponsor
- Abbell AB
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 14, 2017
- Completion date
- February 8, 2019
- Enrollment
- 69 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
onychomycosis of toenail